Stay updated on STORM Clinical Trial - Selinexor in Refractory Myeloma
Sign up to get notified when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.

Latest updates to the STORM Clinical Trial - Selinexor in Refractory Myeloma page
- Check2 days agoChange DetectedA new revision entry 'Revision: v3.3.3' was added to the study record history; the footer now removes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check38 days agoChange DetectedRemoved the site-wide funding-status banner about government delays. This banner did not affect the study data or the history of this trial record.SummaryDifference0.4%

- Check52 days agoChange DetectedThe screenshots show updates to the record history (additional version entries and status notes) rather than substantive changes to core study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedAdds a government-status notice and a new software version (v3.2.0); removes the old version tag (v3.1.0).SummaryDifference10%

- Check87 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.2%

Stay in the know with updates to STORM Clinical Trial - Selinexor in Refractory Myeloma
Enter your email address, and we'll notify you when there's something new on the STORM Clinical Trial - Selinexor in Refractory Myeloma page.